首页> 外文期刊>Drug development and industrial pharmacy >Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler
【24h】

Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler

机译:光学粒度的比较测量悬浮计量吸入器粒度的粒径和级联剥夺

获取原文
获取原文并翻译 | 示例
           

摘要

Optical techniques for the particle size characterization of metered dose inhaler (MDI) suspensions have been developed as an alternative to the labor-intensive and time-consuming impaction method. In this study, a laser diffraction (LD) apparatus with a liquid cell ("wet cell" method) and a "time-of-flight" apparatus named aerodynamic particle sizer (APS) were utilized to assess MDI suspensions with varied formulation compositions and storage conditions. The results were compared with the conventional Anderson cascade impaction (ACI) data. The two optical methods were able to detect the changes in particle size distributions between formulations, yet to a lesser extent than those observed using the cascade impaction methodology. The median aerodynamic particle size measured by the APS method and the median geometric particle size obtained from the LD method were linearly correlated with the corresponding ACI results in the range of 2-5 mu m. It was also found that the APS measurement was biased towards the finer particle size region and resulted in overestimated fine particle fraction (FPF) values which were 2-3 times folds of the ACI results. In conclusion, the optical particle sizing techniques may, under some circumstances, be viable techniques for the rapid assessment of MDI suspensions. The "wet cell" LD method, in particular, is found to be a valuable means of detecting active pharmaceutical ingredient (API) particle size changes in an MDI suspension. Using both the LD and the APS methods in early formulation screening followed by a final assessment with cascade impaction analysis can improve the efficiency of MDI formulation development.
机译:已经开发了计量剂量吸入器(MDI)悬浮液(MDI)悬浮液的粒度表征的光学技术作为劳动密集型和耗时的拨除去方法的替代方案。在该研究中,利用具有液体电池的激光衍射(LD)装置(“湿细胞”方法)和命名空气动力学粒子Sizer(APS)的“飞行时间”装置,评估具有不同配方组合物的MDI悬浮液贮藏条件。将结果与传统的Anderson级联校准(ACI)数据进行比较。两种光学方法能够检测制剂之间的粒度分布的变化,但在较小程度上的程度小于使用级联拨入方法观察到的程度。通过APS方法测量的中值空气动力学粒度和从LD方法获得的中值几何粒度与相应的ACI线性相关,导致2-5μm的范围。还发现APS测量朝向更精细的粒度区域偏置,并导致高稳定的细粒级分(FPF)值,其为ACI结果的2-3倍。总之,光学粒度尺寸在某些情况下可以是用于快速评估MDI悬浮液的可行技术。特别是“湿细胞”Ld方法,特别是检测MDI悬浮液中活性药物成分(API)粒度变化的有价值手段。利用LD和APS方法在早期配方筛选中,随后与级联拨入分析进行最终评估,可以提高MDI配方发育的效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号